parkinson's disease triple agonist glp-1 gip glucagon clinical trial Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research Glucagon-like peptide-1 receptor agonists in
Description
Triple agonist (GLP-1/GIP/Glucagon), under clinical investigation
10.91.0 Eq/min/gkw)
Ozempic, Wegovy, Zepbound, and Mounjaro are GLP-1 medications that help lower blood sugar
Importantly, increasing the endogenous production of GLP-1 by different mechanisms or by increasing the number of intestinal L-cells that tend to produce this hormone may be another effective therapeutic approach to managing T2DM
Expert Guidance Available in Coral Gables and Pinecrest, FL.
